Improving Dynamic Balance and Gait Adaptability Using Treadmill Training

Sponsor
Fondazione Don Carlo Gnocchi Onlus (Other)
Overall Status
Unknown status
CT.gov ID
NCT03201692
Collaborator
(none)
48
1
2
21.3
2.3

Study Details

Study Description

Brief Summary

Balance and gait problems in subjects with neurological disease lead to reduced mobility, loss of independence and frequent falls. Treadmill training is a widely used form of treatment and it has been used in subjects with neurological disease to ameliorate walking and balance deficits. The Virtual Reality Treadmill as a therapeutic tool has been recently introduced to practice gait adaptability elicited by aligning foot placement relative to the projected visual context.

Forty-eight subjects with neurological disease will receive treadmill training treatment randomly divided in Traditional Treadmill training and Virtual Reality Treadmill training.

The aim of this randomized controlled study is to assess whether Treadmill training with Virtual Reality is better than Traditional Treadmill training in improving dynamic balance and cognitive aspects in subjects with neurological diseases.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual Reality Treadmill Training
  • Device: Treadmill training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Improving Dynamic Balance and Gait Adaptability Using Treadmill Training With Visual Cues in Subjects With Neurological Disorders: Design of a Pilot Study
Actual Study Start Date :
Jul 1, 2017
Anticipated Primary Completion Date :
Apr 10, 2019
Anticipated Study Completion Date :
Apr 10, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Treadmill Training

40' treadmill training walking holding the handrail

Device: Treadmill training
Subjects in the active comparator group will receive 40 minutes walking training aimed to improve velocity and endurance.

Experimental: Virtual Reality Treadmill Training

40' treadmill training walking with virtual visual and auditory cues

Device: Virtual Reality Treadmill Training
Subjects in the experimental group will receive 40 minutes comprising exercises focused on improving dynamic balance following auditory and visual cues.
Other Names:
  • C-mill treadmill
  • Outcome Measures

    Primary Outcome Measures

    1. Change in the Modified Dynamic Gait Index [Change from Baseline Modified Dynamic Gait Index scores at 3-5 weeks]

      Tool used to assess dynamic balance

    2. Change in the 6 minutes walking test [Change from Baseline 6 minutes walking test scores at 3-5 weeks]

      tool used to assess walking endurance

    Secondary Outcome Measures

    1. Change in Activity Balance Confidence [Change from Baseline Activity Balance Confidence scores at 3-5 weeks]

      Tool used to assess of balance confidence in daily life activities

    2. Change in 10-meter walking test [Change from Baseline10-meter walking test scores at 3-5 weeks]

      Tool used to assess walking speed in 3 different conditions ( normal speed, fastest speed, cognitive dual task)

    3. Change in Trial Making test [Change from Baseline Trial Making test scores at 3-5 weeks]

      The Trail Making Test is a neuropsychological tapping visual attention and task switching. The test can provide information about visual search speed, scanning, speed of processing, mental flexibility, as well as executive functioning.

    4. Change in Raven's Matrices [Change from Baseline Raven's Matrices scores at 3-5 weeks]

      Test used in measuring abstract reasoning and regarded as a non-verbal estimate of fluid intelligence.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of Multiple Sclerosis (no relapse within the previous three months;), Parkinsons Disease (Hoenhn and Yahr Scale ≤4), Stroke (Time from onset >2 months)

    • Able to walk 20 meters with or without assistive device

    • Cognitive impairment (MMSE score ≥ 21)

    Exclusion Criteria:
    • Unable to understand the aim of the study and unable to sign the informed consent

    • Steroidal drugs therapy for subjects with Multiple Sclerosis

    • Subjects with Psychiatric disorders

    • Subjects with Visual impairments

    • Subjects with cardiovascular disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Don Gnocchi Foundation Milan Italy 20148

    Sponsors and Collaborators

    • Fondazione Don Carlo Gnocchi Onlus

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Davide Cattaneo, Research Coordinator, LaRiCE Lab, PhD, Fondazione Don Carlo Gnocchi Onlus
    ClinicalTrials.gov Identifier:
    NCT03201692
    Other Study ID Numbers:
    • NCT02960984UL_SM
    First Posted:
    Jun 28, 2017
    Last Update Posted:
    Jul 27, 2017
    Last Verified:
    Jul 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2017